Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Steven Conlan

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Biosensors & Bioelectronics|April 7, 2020
Non-invasive molecular assessment of human embryo development and implantation potentialCatarina M Abreu, Victoria Thomas, Paul Knaggs, et al.
Cancers|April 3, 2021
Dinaciclib, a Bimodal Agent Effective against Endometrial CancerDavid Howard, David James, Kate Murphy, et al.
Journal for Immunotherapy of Cancer|October 31, 2019
Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancerGareth D Healey, Belen Pan-Castillo, Jezabel Garcia-Parra, et al.
Molecular Cancer Therapeutics|March 7, 2026
Distinct H3K27 methylation states drive cellular responses to the histone demethylase inhibitor GSK-J4 in ovarian cancer cellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Molecular Cancer Therapeutics|April 27, 2026
Distinct H3K27 Methylation States Drive Cellular Responses to the Histone Demethylase Inhibitor GSK-J4 in Ovarian Cancer CellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Cancers|August 7, 2021
Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance DevelopmentTabea L Bauer, Katrin Collmar, Till Kaltofen, et al.
Clinical Epigenetics|April 14, 2023
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cellsMarcos Quintela, David W James, Agne Pociute, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Biosensors & Bioelectronics|April 7, 2020
Non-invasive molecular assessment of human embryo development and implantation potentialCatarina M Abreu, Victoria Thomas, Paul Knaggs, et al.
Cancers|April 3, 2021
Dinaciclib, a Bimodal Agent Effective against Endometrial CancerDavid Howard, David James, Kate Murphy, et al.
Journal for Immunotherapy of Cancer|October 31, 2019
Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancerGareth D Healey, Belen Pan-Castillo, Jezabel Garcia-Parra, et al.
Molecular Cancer Therapeutics|March 7, 2026
Distinct H3K27 methylation states drive cellular responses to the histone demethylase inhibitor GSK-J4 in ovarian cancer cellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Molecular Cancer Therapeutics|April 27, 2026
Distinct H3K27 Methylation States Drive Cellular Responses to the Histone Demethylase Inhibitor GSK-J4 in Ovarian Cancer CellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Cancers|August 7, 2021
Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance DevelopmentTabea L Bauer, Katrin Collmar, Till Kaltofen, et al.
Clinical Epigenetics|April 14, 2023
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cellsMarcos Quintela, David W James, Agne Pociute, et al.
Pageof 5